ARTICLE | Clinical News
MBN-101: Phase IIa started
June 27, 2016 7:00 AM UTC
Microbion began a single-blind, placebo-controlled, U.S. Phase IIa trial to evaluate single doses of 0.5, 1.5 and 5 ug/cm 2 MBN-101 applied intraoperatively to infected osteosynthesis sites in about 3...